Počet záznamov: 1
Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
Názov Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia Autor Šimoničová Kristína 1995- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS Spoluautori Janotka Ľuboš 1992- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS Kavcová Helena 1965- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS Sulová Zdena 1957- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Breier Albert 1957- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS RID ORCID Messingerová Lucia 1985- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Zdroj.dok. Drug Resistance Updates. Vol. 61 (2022), art. no. 100805 Jazyk dok. eng - angličtina Krajina GB - Veľká Británia URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy ZHAI, Xingjian - JIANG, Xiaoyan. Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias. In BIOMEDICINES, 2022, vol. 10, no. 8, pp. Dostupné na: https://doi.org/10.3390/biomedicines100811341. SNIEGOCKA, Martyna - LICCARDO, Francesca - FAZI, Francesco - MASCIARELLI, Silvia. Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia. In DRUG RESISTANCE UPDATES, 2022, vol. 64, no., pp. ISSN 1368-7646. Dostupné na: https://doi.org/10.1016/j.drup.2022.100853. SINGH, Deepshikha - ASSARAF, Yehuda G. - GACCHE, Rajesh N. Long non-coding RNA mediated drug resistance in breast cancer. In DRUG RESISTANCE UPDATES, 2022, vol. 63, no., pp. ISSN 1368-7646. Dostupné na: https://doi.org/10.1016/j.drup.2022.100851. DOMINGUEZ-ALVAREZ, Enrique - RACZ, Balint - MARC, Malgorzata Anna - NASIM, Muhammad Jawad - SZEMEREDI, Nikoletta - VIKTOROVA, Jitka - JACOB, Claus - SPENGLER, Gabriella. Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents. In DRUG RESISTANCE UPDATES, 2022, vol. 63, no., pp. ISSN 1368-7646. Dostupné na: https://doi.org/10.1016/j.drup.2022.100844. XIONG, Zhenchong - YANG, Lin - LI, Ning - FU, Jianchang - LIU, Peng - SUN, Peng - WEI, Weidong - XIE, Xiaoming. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent beta-catenin nuclear accumulation. In CLINICAL AND TRANSLATIONAL MEDICINE, 2022, vol. 12, no. 12, pp. ISSN 2001-1326. Dostupné na: https://doi.org/10.1002/ctm2.1133. YE, G.H. - WANG, J. - YANG, W.L. - LI, J.Y. - YE, M. - JIN, X.F. The roles of KLHL family members in human cancers. In AMERICAN JOURNAL OF CANCER RESEARCH. ISSN 2156-6976, 2022, vol. 12, no. 11, p. 5105-5139. COSTA, P.M.D. - SALES, S.L.A. - PINHEIRO, D.P. - PONTES, L.Q. - MARANHAO, S.S. - PESSOA, C.D. - FURTADO, G.P. - FURTADO, C.L.M. Epigenetic reprogramming in cancer: From diagnosis to treatment. In FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. ISSN 2296-634X, FEB 14 2023, vol. 11. Dostupné na: https://doi.org/10.3389/fcell.2023.1116805. LONG, H.D. - HOU, Y. - LI, J. - SONG, C.H. - GE, Z. Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. APR 2023, vol. 24, no. 7. Dostupné na: https://doi.org/10.3390/ijms24076816. AWADA, H. - GURNARI, C. - XIE, Z.E. - BEWERSDORF, J.P. - ZEIDAN, A.M. What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. In CANCERS. APR 2023, vol. 15, no. 8. Dostupné na: https://doi.org/10.3390/cancers15082248. WANG, T. - LIU, P. - YANG, J.M. Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignancies. In GENES & DISEASES. ISSN 2352-4820, MAY 2023, vol. 10, no. 3, p. 891-900. Dostupné na: https://doi.org/10.1016/j.gendis.2022.06.001. SHEN, J.Z. - WANG, Q.R. - MAO, Y.A. - GAO, W. - DUAN, S.W. Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. In MEDCOMM. JUN 2023, vol. 4, no. 3. Dostupné na: https://doi.org/10.1002/mco2.288. ABDEL-AZIZ, A.K. Advances in acute myeloid leukemia differentiation therapy: A critical review. In BIOCHEMICAL PHARMACOLOGY. ISSN 0006-2952, SEP 2023, vol. 215. Dostupné na: https://doi.org/10.1016/j.bcp.2023.115709. ZHENG, P.D. - MAO, Z.Y. - LUO, M. - ZHOU, L. - WANG, L.L. - LIU, H.G. - LIU, W. - WEI, S. Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma. In CANCER CELL INTERNATIONAL. SEP 29 2023, vol. 23, no. 1. Dostupné na: https://doi.org/10.1186/s12935-023-03082-7. ZHAO, Y.F. - ZHANG, Y. - LU, W.Y. - SUN, R. - GUO, R.T. - CAO, X.P. - LIU, X.Z. - LYU, C. - ZHAO, M.F. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia. In BMC MEDICAL GENOMICS. NOV 18 2023, vol. 16, no. 1. Dostupné na: https://doi.org/10.1186/s12920-023-01735-0. WU, Y. - ZEHNLE, P.M.A. - RAJAK, J. - KOLECI, N. - ANDRIEUX, G. - GALLEGO-VILLAR, L. - AUMANN, K. - BOERRIES, M. - NIEMEYER, C.M. - FLOTHO, C. - BOHLER, S. - ERLACHER, M. BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia. In LEUKEMIA. ISSN 0887-6924, JAN 2024, vol. 38, no. 1, p. 136-148. Dostupné na: https://doi.org/10.1038/s41375-023-02079-5. SANEI, M. - AMIRHEIDARI, B. - SATARZADEH, N. Mutuality of epigenetic and nanoparticles: two sides of a coin. In HELIYON. JAN 15 2024, vol. 10, no. 1. Dostupné na: https://doi.org/10.1016/j.heliyon.2023.e23679. LUO, Y.W. - FENG, X.M. - LANG, W. - XU, W.H. - WANG, W. - MEI, C. - YE, L. - ZHU, S.H. - WANG, L. - ZHOU, X.P. - ZENG, H.M. - MA, L.Y. - REN, Y.L. - JIN, J. - XU, R.Z. - HUANG, G. - TANG, H.Y. Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes. In JOURNAL OF CLINICAL INVESTIGATION. ISSN 0021-9738, APR 15 2024, vol. 134, no. 8. Dostupné na: https://doi.org/10.1172/JCI172468. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2022 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1016/j.drup.2022.100805 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia.pdf Neprístupný/archív 4.7 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 22.841 Q1 3.845 Q1
Počet záznamov: 1